Astellas Pharma Executive and Leadership Team

Atsushi Kitamura, the Chief Financial Officer at Astellas Pharma, directs all global fiscal planning and capital allocation strategies. Managing the financial health of the organization, the Chief Financial Officer oversees budgetary compliance and investment analysis to support pharmaceutical manufacturing goals. This leadership role involves coordinating with the Board to ensure long-term economic stability across international markets. By optimizing resource distribution, Atsushi Kitamura directly impacts the ability of the company to fund critical research and development initiatives. The Chief Financial Officer maintains rigorous oversight of fiscal reporting, ensuring transparency and alignment with corporate objectives. Through precise financial modeling and risk assessment, Kitamura secures the necessary capital to drive expansion in the competitive pharmaceutical sector. This executive leadership ensures that every investment aligns with the core mission of delivering high-quality medical products to patients worldwide while maximizing shareholder value through disciplined fiscal management.

Ruibo Tang, the Senior Secretary To President at Astellas Pharma, directs the administrative operations and executive communication flow for the office of the President. Overseeing the daily schedule and strategic priorities of the President, the Senior Secretary To President ensures that executive decision-making processes remain efficient and well-informed. This leadership role involves coordinating high-level meetings and managing sensitive information to support the strategic direction of the company. By facilitating effective communication between the President and other C-suite leaders, Ruibo Tang directly impacts the cohesion of the executive team. The Senior Secretary To President manages the administrative infrastructure that supports the company's leadership in navigating the complex pharmaceutical industry. Through meticulous organization and proactive support, Tang ensures that the President can focus on driving the core mission of the organization and achieving long-term growth objectives.

Dewi Koesoema, the President & Director at Astellas Pharma, directs the overall corporate strategy and operational vision for the organization. Overseeing all business units, the President & Director ensures that the company maintains its focus on pharmaceutical manufacturing and global market expansion. This leadership role involves setting the strategic agenda and guiding the executive team toward achieving long-term growth and innovation goals. By fostering a culture of excellence, Dewi Koesoema directly impacts the ability of the company to deliver advanced medical solutions to patients. The President & Director manages the relationship with the Board and external stakeholders to ensure alignment with the corporate mission. Through decisive leadership and a commitment to scientific advancement, Koesoema drives the company's success in the competitive global healthcare market, ensuring that all operations contribute to the overarching goal of improving patient health.

Sand'Eria Lewis, the Head of Strategic Collaboration Chief of Staff at Astellas Pharma, architects complex partnerships to accelerate drug discovery and market access. Overseeing cross-functional alliances, the Head of Strategic Collaboration Chief of Staff ensures that external research collaborations align with internal manufacturing capabilities. This leadership role involves managing high-level stakeholder relationships to foster innovation within the pharmaceutical pipeline. By streamlining communication between research teams and external partners, Sand'Eria Lewis directly impacts the speed of product development cycles. The Head of Strategic Collaboration Chief of Staff drives the integration of new technologies into existing workflows, enhancing operational efficiency across global regions. Through strategic negotiation and alliance management, Lewis secures competitive advantages in the global market. This executive leadership ensures that collaborative efforts remain focused on the primary mission of advancing patient care through scientific excellence and robust industry partnerships.

Tomohiro Kusawake, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office at Astellas Pharma, directs the operational framework for all pharmaceutical research activities. Overseeing the CRDO Office, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office ensures that scientific discovery processes meet rigorous quality standards. This leadership role involves coordinating laboratory resources and clinical trial timelines to support the development of new therapeutic agents. By optimizing the research pipeline, Tomohiro Kusawake directly impacts the ability of the company to bring life-saving medications to market. The Vice President, Chief of Staff for Research and Development, Head of CRDO Office manages complex project portfolios, ensuring alignment with long-term corporate strategy. Through meticulous oversight of research operations, Kusawake drives innovation and maintains the competitive edge of the organization in the global pharmaceutical landscape.

Matthew Brieger, the Chief Marketing Officer & Manager, External Manufacturing Integration at Astellas Pharma, directs the commercialization strategies for pharmaceutical products while managing external supply chain partnerships. Overseeing the integration of third-party manufacturing, the Chief Marketing Officer & Manager, External Manufacturing Integration ensures that production capacity meets global market demand. This leadership role involves aligning marketing campaigns with manufacturing output to optimize product availability. By synchronizing commercial efforts with supply chain logistics, Matthew Brieger directly impacts the revenue growth and market penetration of the company. The Chief Marketing Officer & Manager, External Manufacturing Integration manages complex vendor relationships to ensure quality and compliance across all external production sites. Through strategic planning and operational oversight, Brieger secures the supply chain integrity necessary to support the company's mission of delivering essential medicines to patients across diverse international markets.

Dhanush Adiga, the Chief Marketing Officer, Lead Office (Reporting & Analytics) at Astellas Pharma, directs the data-driven commercial strategy through advanced reporting and market analytics. Overseeing the Lead Office, the Chief Marketing Officer, Lead Office (Reporting & Analytics) ensures that marketing decisions rely on precise performance metrics and consumer insights. This leadership role involves analyzing market trends to refine product positioning and promotional effectiveness. By leveraging data analytics, Dhanush Adiga directly impacts the efficiency of commercial operations and the accuracy of sales forecasting. The Chief Marketing Officer, Lead Office (Reporting & Analytics) manages the integration of business intelligence tools to support executive decision-making across the organization. Through rigorous analysis of market performance, Adiga drives the optimization of marketing spend and enhances the overall impact of pharmaceutical product launches in the global healthcare sector.

Kenichi Kazuta, the Chief Marketing Officer, Lead, Office, Strategic Operations at Astellas Pharma, directs the operational execution of global marketing initiatives. Overseeing the Office of Strategic Operations, the Chief Marketing Officer, Lead, Office, Strategic Operations ensures that commercial teams maintain alignment with corporate goals and regulatory requirements. This leadership role involves streamlining internal processes to improve the speed and effectiveness of product marketing campaigns. By optimizing operational workflows, Kenichi Kazuta directly impacts the ability of the company to respond to changing market conditions. The Chief Marketing Officer, Lead, Office, Strategic Operations manages cross-departmental projects to ensure that marketing strategies translate into tangible business outcomes. Through strategic oversight of operational performance, Kazuta drives the implementation of best practices across all marketing functions, supporting the company's mission to provide innovative pharmaceutical solutions to patients worldwide.

Samantha Yuen, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) at Astellas Pharma, directs the human capital strategy and enterprise-wide organizational development programs. Overseeing talent management and corporate culture, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) ensures that the workforce remains aligned with the mission of pharmaceutical innovation. This leadership role involves designing programs that foster professional growth and operational excellence across all departments. By cultivating a high-performance environment, Samantha Yuen directly impacts the ability of the company to attract and retain top-tier talent. The Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) manages the implementation of enterprise programs that drive employee engagement and organizational agility. Through strategic leadership of human resources, Yuen supports the company's long-term goals by building a resilient and capable workforce dedicated to advancing global health.

Carmen Watson, the Associate Director, External Manufacturing Integration at Astellas Pharma, directs the technical coordination between internal teams and external manufacturing partners. Overseeing the integration of outsourced production, the Associate Director, External Manufacturing Integration ensures that all third-party facilities adhere to strict quality and safety standards. This leadership role involves managing the day-to-day operational interface to prevent supply chain disruptions. By maintaining rigorous oversight of external manufacturing processes, Carmen Watson directly impacts the reliability and consistency of the pharmaceutical product supply. The Associate Director, External Manufacturing Integration coordinates with quality assurance and logistics departments to ensure seamless production cycles. Through proactive management of external partnerships, Watson secures the operational stability required to meet global demand for the company's medical products, ultimately supporting the broader mission of improving patient health outcomes through reliable manufacturing.